Why is "Cepheid" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-23 04:07:11
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
A Cepheid variable is a type of variable star that pulsates radially, varying in both diameter and temperature. It changes in brightness, with a well-defined stable period and amplitude. Cepheids are important cosmic benchmarks for scaling galactic and extragalactic distances; a strong direct relationship exists between a Cepheid variable's luminosity and its pulsation period.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Cepheid Receives FDA Clearance for Xpert® GI Panel to Support Broad Detection of Gastrointestinal Pathogens - PR Newswire
-
CDC Selects Cepheid as National Collaborator for Rapid Diagnostic Development - Clinical Lab Products
-
Cepheid Xpert MRSA Cycle Threshold in Discordant Colonization Results and as a Quantitative Measure of Nasal Colonization Burden - ASM Journals
-
Cepheid Selected by CDC as National Collaborator to Accelerate Rapid Diagnostic Development for Future Pandemics - Infection Control Today
-
Cepheid Positions HCV Test Portfolio for Potential U.S. Hepatitis C Elimination Push - TipRanks
-
Cepheid announces WHO prequalification of the Xpert® MTB/XDR test - European AIDS Treatment Group
-
FDA clears Cepheid’s Xpert GI Panel for pathogen detection - Medical Device Network
-
Rapid HCV Test Provides Opportunity for Single Visit Diagnosis and Treatment Encounters - Contagion Live
-
Radiometer, Leica Biosystems and Cepheid to come together at IBMS Congress 2025 on Stand 109 - News-Medical
-
Silicon Valley layoffs deepen as three more tech companies announce job cuts - San Francisco Chronicle
-
DoD Awards a Maximum $565.8 Million Contract to Cepheid for Point-of-Care Medical Tests and Analyzers - U.S. Department of War (.gov)
-
Type II Cepheids: period-luminosity-metallicity relations for the Population II distance scale - Frontiers
-
FDA Clears Cepheid’s Xpert GI Panel - Medical Product Outsourcing
-
Cepheid Selected by CDC as National Collaborator, Advancing Rapid Diagnostic Innovation to Strengthen U.S. Pandemic Preparedness - PR Newswire
-
Testing tongue swab samples by Cepheid Xpert MTB/RIF Ultra: comparison of two protocols applied to samples from persons with low-bacillary load TB - ASM Journals
-
FDA Clears Cepheid’s Multiplex GI Pathogen Panel - Clinical Lab Products
-
FDA Clears Rapid Multiplex GI Test That Could Transform Outbreak Detection and Infection Prevention - Infection Control Today
-
Cepheid Highlights Diagnostic Innovation Focus Ahead of ESCMID Global 2026 - TipRanks
-
Health Canada grants licence to Cepheid’s HCV test - Medical Device Network
-
Cepheid Announces World Health Organization Prequalification of the Xpert® MTB/XDR test - PR Newswire
-
Performance analysis of the GeneXpert respiratory panel prototype assay for the diagnosis of viral and bacterial upper respiratory tract infections - ASM Journals
-
Cepheid Highlights Role in Global Antimicrobial Resistance Diagnostics Agenda - TipRanks
-
Cepheid Showcases Rapid PCR and Viral Load Applications at ASICON 2026 - TipRanks
-
Uncrowding Cepheids in the Near Infrared - NASA Science (.gov)
-
Testing tongue swab samples by Cepheid Xpert MTB/RIF Ultra: comparison of two protocols applied to samples from persons with low-bacillary load TB - ASM Journals
-
FCMC First Hospital in Nation to Offer Cepheid GI Pathogen Panel - 95.1 The Bull
-
Dark matter may be answer to why stars near the Milky Way’s core are muted - University of Hawaii System
-
Leadership Culture and Talent Focus at Diagnostics Firm Cepheid - TipRanks
-
Cepheid Highlights Focus on C. difficile Diagnostic Strategy and Stewardship - TipRanks
-
R&D Leadership Culture at Cepheid Emphasizes Innovation and Clinical Impact - TipRanks
-
Danaher subsidiary Cepheid implements layoffs - The Business Journals
-
Cepheid Highlights Clinical Focus on C. difficile Diagnostics and Stewardship - TipRanks
-
Cepheid Marks 30 Years in Molecular Diagnostics With Forward-Looking Focus - TipRanks
-
Cepheid Highlights C. difficile Diagnostic Strategy With Global Educational Webinar - TipRanks
-
Danaher Corporation Q3 2025 Financial Results - TradingView
-
Cepheid and Oxford Nanopore Technologies partner to advance automated sequencing-based solutions - Drug Discovery News
-
Cepheid Targets Developer Talent and Innovation Through Code To Cure Hackathon - TipRanks
-
FDA-cleared GI test detects ‘most likely causes’ of diarrheal syndromes - Healio
-
Public-private partnerships are critical for rapid response to infectious disease threats - Frontiers
-
Cepheid Highlights Importance of HPV Molecular Diagnostics - TipRanks
-
Cepheid to lay off 167 people in California - medtechdive.com
-
Danaher Discusses Diagnostics Biz at ADLM With Refocus on Partnerships in Key Disease Areas - 360Dx
-
Cepheid Emphasizes Antimicrobial Stewardship and Diagnostics at AMR 2026 - TipRanks
-
Cepheid Highlights FDA-Cleared Xpert GI Panel Expansion on GeneXpert Platform - TipRanks
-
Danaher Q3 2025 Earnings Beat Estimates | Bioprocessing & Respiratory Testing Drive Growth - News and Statistics - IndexBox
-
Stretched in a cross pattern: Our neighboring galaxy is pulled in two axes, new evidence indicates - Phys.org
-
Danaher predicts $350M tariff hit, moves to mitigate impact on profits - medtechdive.com
-
DBS in Action: Cepheid’s COVID-19 Response - Danaher Corporation
-
Cepheid Receives Health Canada Licence for Xpert® HCV VL Fingerstick - newswire.ca
-
Time for $5 - MSF Access
-
College of Science | - | UAH researcher unveils new map of Milky Way galaxy in atomic hydrogen, revealing its clumped “flocculent” nature for first time | The University of Alabama in Huntsville - The University of Alabama in Huntsville
-
TB test price reduction by Cepheid and Danaher is an important step in the right direction - MSF Access
-
Cepheid Receives Health Canada Licence for Xpert® HIV-1 Viral Load XC - newswire.ca
-
Cepheid charges four times more than it should per COVID-19 test - Doctors Without Borders
-
G2M Appoints Diagnostics Pioneer John Bishop, Former Cepheid CEO, to Its Advisory Board - eHealth Magazine
-
Is the Hubble Tension Resolved? - astronomynow.com
-
Polaris, the North Star - Center for Astrophysics | Harvard & Smithsonian
-
Cepheid to cut more than 600 employees in California - medtechdive.com
-
User Clip: Trump pronouncing Cepheid - C-SPAN
-
Cepheid charging four times more than it should for coronavirus COVID-19 tests - MSF
-
Cepheid Receives FDA Authorization with CLIA Waiver for Xpert® HCV - PR Newswire
-
Comparison of the diagnostic accuracy of the Pluslife Mini Dock RHAM technology with Abbott ID Now and Cepheid GenXpert: A retrospective evaluation study - Nature
-
Letters to Danaher and Cepheid - MSF Access
-
MSF and partners protest medical test maker Cepheid and Danaher at International AIDS Conference - MSF Access
-
FDA updates impact of mutations on COVID-19 tests, adds Cepheid to list of affected products - medtechdive.com
-
As Danaher reports quarterly earnings and increased market share for Cepheid’s GeneXpert medical tests, MSF calls on corporation to drop all test prices to $5 for low- and middle-income countries - MSF Access
-
Cepheid Receives FDA Clearance for GBS Diagnostic Test - Clinical Lab Products
-
Time for $5: Over 200,000 people support MSF’s call for Danaher to make medical tests more affordable - Doctors Without Borders
-
Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests - Doctors Without Borders
-
Novelist John Green launches attack on Cepheid over the price of its TB test - statnews.com
-
Composable as an Enabler of Future Innovation, Part 2 [Interview with Cepheid, Danaher Group] - EPAM
-
Donors bet a U.S. firm could transform disease testing in Africa. Then COVID-19 hit - Reuters
-
Health advocates press Cepheid for cheaper mpox tests - Reuters
-
Cepheid Yourself: Confirming Tensions in the Hubble Expansion - AAS Nova
-
Cepheid Drives Danaher Corporation (DHR) Q2 2024 Success, Hedge Funds Rally Around the Stock - Yahoo Finance
-
Sunnyvale Company Cepheid Receives Approval From FDA for Rapid COVID-19 Test - The Silicon Valley Voice
-
Cepheid gets FDA nod for EUA 45-minute coronavirus test - BioWorld MedTech
-
Biotech company Cepheid lays off 635 in Bay Area, slashes manufacturing staff - SFGATE
-
Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women - ASM Journals
-
Help us stop the profiteering on medical tests - Doctors Without Borders
-
Cepheid wins emergency use nod from FDA for bedside coronavirus test - MassDevice
-
First Look at Extragalactic Cepheid Variable Stars with JWST - AAS Nova
-
Astronomers Only Knew of a Single Binary Cepheid System. Now They Just Found Nine More - Universe Today
-
Testmaker Cepheid to cut more than 600 jobs at Silicon Valley headquarters - Fierce Biotech
-
Cepheid to develop automated molecular test for coronavirus - Medical Device Network
-
Multicenter Evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay - ASM Journals
-
Letter to Cepheid to reinstate launch of GeneXpert Omni TB testing system - MSF Access
-
Cepheid’s Mpox Test Gets Emergency Use Authorization - Clinical Lab Products
-
Bay Area biotech giant to cut hundreds of jobs at Silicon Valley headquarters - San Francisco Chronicle
-
Highly Anticipated Cepheid Omni Point-of-Care System Falls Off Radar - 360Dx
-
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert® Xpress MVP - PR Newswire
-
J&J and Cepheid must expand access to TB drug and tests - Doctors Without Borders
-
Images - ESA/Hubble
-
MSF: TB test price reduction is a step in the right direction - Doctors Without Borders
-
Cepheid Gets Emergency Use Authorization for Rapid COVID Test - Clinical Lab Products
-
Research Company Danaher Is Buying Cepheid for $4 Billion - Fortune
-
Genes2Me onboards John Bishop to advisory board - ET HealthWorld
-
Cepheid Launches Multiplex Vaginal Panel (MVP) to Support More Accurate Women's Health Diagnosis in U.S. - PR Newswire
-
Cepheid Receives Emergency Use Authorization for Xpert Xpress CoV-2/Flu/RSV plus - PR Newswire
-
Cepheid Expands into Non-Acute Care Market - Clinical Lab Products
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.